Immunomodulatory effects of Lactobacillus plantarum and helicobacter pylori CagA + on the expression of selected superficial molecules on monocyte and lymphocyte and the synthesis of cytokines in whole blood culture

Journal of Physiology and Pharmacology

Volumn 63, Issue 3, 2012, Pages 217-224

  Wiese, Malgorzata ^a   Eljaszewicz, A ^a   Andryszczyk, M ^a   Gronek, S ^a   Gackowska, L ^a   Kubiszewska, I ^a   Kaszewski, W ^a   Helmin Basa, A ^a   Januszewska, M ^a   Motyl, I ^b   Wieczynska, J ^c   Michalkiewicz, J ^a,c  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

^c CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

Cytotoxin associated gene a; Helicobacter pylori; Immunomodulation; Interferon ; Interleukin 10; Lactobacillus spp.; Lymphocytes; Monocytes

Indexed keywords

CAGA PROTEIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 2 RECEPTOR GAMMA; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; TUMOR NECROSIS FACTOR ALPHA; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CAGA PROTEIN, HELICOBACTER PYLORI; IL2RA PROTEIN, HUMAN; IMMUNOLOGIC FACTOR;

ADULT; ANTIGEN PRESENTING CELL; ARTICLE; BACTERIAL STRAIN; CELL DIFFERENTIATION; CELL INTERACTION; CELL LEVEL; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOMODULATION; IN VITRO STUDY; LACTOBACILLUS PLANTARUM; LEUKOCYTE; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; MONOCYTE; NORMAL HUMAN; PHENOTYPE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; T LYMPHOCYTE; HELICOBACTER INFECTION; IMMUNOLOGY; MICROBIOLOGY; STOMACH MUCOSA;

ADULT; ANTIGENS, BACTERIAL; ANTIGENS, CD58; BACTERIAL PROTEINS; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LACTOBACILLUS PLANTARUM; LYMPHOCYTES; MONOCYTES; YOUNG ADULT;

EID: 84864012814     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Sheu BS, Cheng HC, Kao AW, et al Pretreatment with Lactobacillusand Bifidobacterium-containing yogurt can improve the efficacy of quadruple therapy in eradicating residual Helicobacter pylori infection after failed triple therapy. Am J Clin Nutr 2006; 83: 864-869.
2. Michalkiewicz J, Krotkiewski M, Gackowska L, et al. Immunomodulujacy wplyw probiotykow na reakcje odpornosciowe. Standardy Medyczne 2003; 9: 10.
3. Clarke TB, Davis KM, Lysenko ES, Zhou AY, Yu Y, Weiser JN. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med 2010; 16: 228-231.
4. Rad R, Brenner L, Bauer S, et al. CD25+/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology 2006; 131: 525-537.
5. Rahimi R, Nikfar S, Rezaie A, Abdollahi M. A meta-analysis of the benefit of probiotics in maintaining remission of human ulcerative colitis: evidence for preventing of disease relapse and maintenance of remission. Arch Med Sci 2008; 4: 5.
6. Ferrand J, Roumanes D, Pitard V, Moreau JF, Megraud F, Lehours P. Modulation of lymphocyte proliferation induced by gastric MALT lymphoma-associated Helicobacter pylori strains. Helicobacter 2008; 13: 167-173.
7. Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006; 19: 449-490.
8. Nikfar S, Darvish-Damavandi M, Abdollahi M. A review and meta-analysis of the efficacy of antibiotics nad probiotics in management of pouchitis. Int J Pharmacol 2010; 6: 9.
9. Lesbros-Pantoflickova D, Corthesy-Theulaz I, Blum AL. Helicobacter pylori and probiotics. J Nutr 2007; 137(3 Suppl. 2): 812s-818s.
10. Gillingham LG, Lescheid DW. Probiotics and mucosal immunity: strain-specific effects on Th1/Th2 cell modulation. Int J Naturopathic Med 2009; 4: 4.
11. Schrezenmeir J, de Vrese M. Probiotics, prebiotics, and synbiotics-approaching a definition. Am J Clin Nutr 2001; 73(Suppl. 2): 361s-364s.
12. Baba N, Samson S, Bourdet-Sicard R, Rubio M, Sarfati M. Commensal bacteria trigger a full dendritic cell maturation program that promotes the expansion of non-Tr1 suppressor T cells. J Leukoc Biol 2008; 84: 468-476.
13. Haller D, Blum S, Bode C, Hammes WP, Schiffrin EJ. Activation of human peripheral blood mononuclear cells by nonpathogenic bacteria in vitro: evidence of NK cells as primary targets. Infect Immun 2000; 68: 752-759.
14. Gackowska L, Michalkiewicz J, Krotkiewski M, HelminBasa A, Kubiszewska I, Dzierzanowska D. Combined effect of different lactic acid bacteria strains on the mode of cytokines pattern expression in human peripheral blood mononuclear cells. J Physiol Pharmacol 2006; 57(Suppl. 9): 13-21.
15. Modzelewska-Banachiewicz B, Ucherek M, Zimecki M, et al. Reactions of N(3) -substituted amidrazones with cis-1,2-cyclohexanedicarboxylic anhydride and biological activities of the products. Arch Pharm (Weinheim) 2012; 345: 486-494.
16. Zimecki M, Artym J, Kocieba M, Pluta K, MorakMlodawska B, Jelen M. The immunosuppressive activities of newly synthesized azaphenothiazines in human and mouse models. Cell Mol Biol Lett 2009; 14: 622-635.
17. Michalkiewicz J, Krotkiewski M, Gackowska L, et al. Immunomodulatory effects of lactic acid bacteria on human peripherial blood mononuclear cells. Microb Ecol Health Dis 2003; 15: 7.
18. Michalkiewicz J, Stachowski J, Barth C, et al. Effect of Pseudomonas aeruginosa exotoxin A on IFN-gamma synthesis: expression of costimulatory molecules on monocytes and activity of NK cell. Immunol Lett 1999; 69: 359-366.
19. Mohamadzadeh M, Olson S, Kalina WV, et al. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci USA 2005; 102: 2880-2885.
20. Shida K, Suzuki T, Kiyoshima-Shibata J, Shimada S, Nanno M. Essential roles of monocytes in stimulating human peripheral blood mononuclear cells with Lactobacillus casei to produce cytokines and augment natural killer cell activity. Clin Vaccine Immunol 2006; 13: 997-1003.
21. Barkman C, Martner A, Hessle C, Wold AE. Soluble bacterial constituents down-regulate secretion of IL-12 in response to intact Gram-positive bacteria. Microbes Infect 2008; 10: 1484-1493.
22. Delvig AA, Lee JJ, Chrzanowska-Lightowlers ZM, Robinson JH. TGF-beta1 and IFN-gamma cross-regulate antigen presentation to CD4 T cells by macrophages. J Leukoc Biol 2002; 72: 163-166.
23. Evans BJ, McDowall A, Taylor PC, Hogg N, Haskard DO, Landis RC. Shedding of lymphocyte function-associated antigen-1 (LFA-1) in a human inflammatory response. Blood 2006;107: 3593-3599.
24. Figdor CG, van Kooyk Y, Keizer GD. On the mode of action of LFA-1. Immunol Today 1990; 11: 277-280.
25. Yusuf-Makagiansar H, Anderson ME, Yakovleva TV, Murray JS, Siahaan TJ. Inhibition of LFA-1/ICAM-1 and VLA-4/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases. Med Res Rev 2002; 22: 146-167.
26. Skrzeczynska-Moncznik J, Bzowska M, Loseke S, Grage-Griebenow E, Zembala M, Pryjma J. Peripheral blood CD14high CD16+ monocytes are main producers of IL-10. Scand J Immunol 2008; 67: 152-159.
27. Lee SW, Hong YS, Chun CM, et al. Anti-inflammatory effects of IL-4 and IL-10 on human polymorphonuclear leukocytes. J Korean Med Sci 2002; 17: 7-14.
28. Saraiva M, O'Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol 2010; 10: 170-181.
29. Kim JM, Kim JS, Yoo DY, et al. Stimulation of dendritic cells with Helicobacter pylori vacuolating cytotoxin negatively regulates their maturation via the restoration of E2F1. Clin Exp Immunol 2011; 166: 34-45.
30. + suppressor T cells regulate pathogen induced inflammation and disease. FEMS Immunol Med Microbiol 2005; 44: 121-127.
31. Ghasemi-Niri SF, Abdolghaffari AH, Fallah-Benakohal S, et al. On the benefit of whey-cultured Lactobacillus casei in murine colitis. J Physiol Pharmacol 2011; 62: 341-346.
32. Wang P, Qi BT, Chen P, et al. CD58 expression of liver tissue in patients with chronic hepatitis B virus infection. Chin Med J 2008; 121: 557-560.
33. Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy review of a new approach. Pharmacol Rev 2003; 55: 241-269.
34. Schmees C, Prinz C, Treptau T, et al. Inhibition of T-cell proliferation by Helicobacter pylori gamma-glutamyl transpeptidase. Gastroenterology 2007; 132: 1820-1833.
35. Belz GT, Masson F. Interleukin-2 tickles T cell memory. Immunity 2010; 32: 7-9.
36. Grebowska A, Moran AP, Bielanski W, et al. Helicobacter pylori lipopolysaccharide activity in human peripheral blood mononuclear leukocyte cultures. J Physiol Pharmacol 2010; 61: 437-442.
37. Cha B, Lim JW, Kim KH, Kim H. 15-deoxy-D12,14prostaglandin J2 suppresses RANTES expression by inhibiting NADPH oxidase activation in Helicobacter pylori-infected gastric epithelial cells. J Physiol Pharmacol 2011; 62: 167-174.